These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

1177 related items for PubMed ID: 14697462

  • 1. Comparisons of effects of statins (atorvastatin, fluvastatin, lovastatin, pravastatin, and simvastatin) on fasting and postprandial lipoproteins in patients with coronary heart disease versus control subjects.
    Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ.
    Am J Cardiol; 2004 Jan 01; 93(1):31-9. PubMed ID: 14697462
    [Abstract] [Full Text] [Related]

  • 2. Effects of atorvastatin on fasting and postprandial lipoprotein subclasses in coronary heart disease patients versus control subjects.
    Schaefer EJ, McNamara JR, Tayler T, Daly JA, Gleason JA, Seman LJ, Ferrari A, Rubenstein JJ.
    Am J Cardiol; 2002 Oct 01; 90(7):689-96. PubMed ID: 12356379
    [Abstract] [Full Text] [Related]

  • 3. Cost-effectiveness analysis of cholesterol-lowering therapies in Spain.
    Plans-Rubió P.
    Am J Cardiovasc Drugs; 2006 Oct 01; 6(3):177-88. PubMed ID: 16780391
    [Abstract] [Full Text] [Related]

  • 4. Comparing the effects of five different statins on the HDL subpopulation profiles of coronary heart disease patients.
    Asztalos BF, Horvath KV, McNamara JR, Roheim PS, Rubinstein JJ, Schaefer EJ.
    Atherosclerosis; 2002 Oct 01; 164(2):361-9. PubMed ID: 12204809
    [Abstract] [Full Text] [Related]

  • 5. Comparative dose efficacy study of atorvastatin versus simvastatin, pravastatin, lovastatin, and fluvastatin in patients with hypercholesterolemia (the CURVES study).
    Jones P, Kafonek S, Laurora I, Hunninghake D.
    Am J Cardiol; 1998 Mar 01; 81(5):582-7. PubMed ID: 9514454
    [Abstract] [Full Text] [Related]

  • 6. Low-density lipoprotein cholesterol (LDL-C) levels and LDL-C goal attainment among elderly patients treated with rosuvastatin compared with other statins in routine clinical practice.
    Harley CR, Gandhi S, Blasetto J, Heien H, Sasane R, Nelson SP.
    Am J Geriatr Pharmacother; 2007 Sep 01; 5(3):185-94. PubMed ID: 17996658
    [Abstract] [Full Text] [Related]

  • 7. Treating patients with documented atherosclerosis to National Cholesterol Education Program-recommended low-density-lipoprotein cholesterol goals with atorvastatin, fluvastatin, lovastatin and simvastatin.
    Brown AS, Bakker-Arkema RG, Yellen L, Henley RW, Guthrie R, Campbell CF, Koren M, Woo W, McLain R, Black DM.
    J Am Coll Cardiol; 1998 Sep 01; 32(3):665-72. PubMed ID: 9741509
    [Abstract] [Full Text] [Related]

  • 8. Achieving and maintaining National Cholesterol Education Program low-density lipoprotein cholesterol goals with five statins.
    Andrews TC, Ballantyne CM, Hsia JA, Kramer JH.
    Am J Med; 2001 Aug 15; 111(3):185-91. PubMed ID: 11530028
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparative efficacy study of atorvastatin vs simvastatin, pravastatin, lovastatin and placebo in type 2 diabetic patients with hypercholesterolaemia.
    Gentile S, Turco S, Guarino G, Sasso CF, Amodio M, Magliano P, Salvatore T, Corigliano G, Agrusta M, De Simone G, Gaeta I, Oliviero B, Torella R.
    Diabetes Obes Metab; 2000 Dec 15; 2(6):355-62. PubMed ID: 11225965
    [Abstract] [Full Text] [Related]

  • 11. Comparison of once-daily, niacin extended-release/lovastatin with standard doses of atorvastatin and simvastatin (the ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation [ADVOCATE]).
    Bays HE, Dujovne CA, McGovern ME, White TE, Kashyap ML, Hutcheson AG, Crouse JR, ADvicor Versus Other Cholesterol-Modulating Agents Trial Evaluation.
    Am J Cardiol; 2003 Mar 15; 91(6):667-72. PubMed ID: 12633795
    [Abstract] [Full Text] [Related]

  • 12. An economic analysis of the Atorvastatin Comparative Cholesterol Efficacy and Safety Study (ACCESS).
    Smith DG, McBurney CR.
    Pharmacoeconomics; 2003 Mar 15; 21 Suppl 1():13-23. PubMed ID: 12648031
    [Abstract] [Full Text] [Related]

  • 13. Managing dyslipidemia in the high-risk patient.
    Stein EA.
    Am J Cardiol; 2002 Mar 07; 89(5A):50C-57C. PubMed ID: 11900720
    [Abstract] [Full Text] [Related]

  • 14. Lowering effects of four different statins on serum triglyceride level.
    Branchi A, Fiorenza AM, Rovellini A, Torri A, Muzio F, Macor S, Sommariva D.
    Eur J Clin Pharmacol; 1999 Sep 07; 55(7):499-502. PubMed ID: 10501818
    [Abstract] [Full Text] [Related]

  • 15. Guidelines for lowering lipids to reduce coronary artery disease risk: a comparison of rosuvastatin with atorvastatin, pravastatin, and simvastatin for achieving lipid-lowering goals.
    Shepherd J, Hunninghake DB, Barter P, McKenney JM, Hutchinson HG.
    Am J Cardiol; 2003 Mar 06; 91(5A):11C-17C; discussion 17C-19C. PubMed ID: 12646338
    [Abstract] [Full Text] [Related]

  • 16. Effects of atorvastatin versus other statins on fasting and postprandial C-reactive protein and lipoprotein-associated phospholipase A2 in patients with coronary heart disease versus control subjects.
    Schaefer EJ, McNamara JR, Asztalos BF, Tayler T, Daly JA, Gleason JL, Seman LJ, Ferrari A, Rubenstein JJ.
    Am J Cardiol; 2005 May 01; 95(9):1025-32. PubMed ID: 15842965
    [Abstract] [Full Text] [Related]

  • 17. Safety and efficacy of atorvastatin in heart transplant recipients.
    Patel DN, Pagani FD, Koelling TM, Dyke DB, Baliga RR, Cody RJ, Lake KD, Aaronson KD.
    J Heart Lung Transplant; 2002 Feb 01; 21(2):204-10. PubMed ID: 11834348
    [Abstract] [Full Text] [Related]

  • 18. Effects of rosuvastatin versus atorvastatin, simvastatin, and pravastatin on non-high-density lipoprotein cholesterol, apolipoproteins, and lipid ratios in patients with hypercholesterolemia: additional results from the STELLAR trial.
    Jones PH, Hunninghake DB, Ferdinand KC, Stein EA, Gold A, Caplan RJ, Blasetto JW, Statin Therapies for Elevated Lipid Levels Compared Across Doses to Rosuvastatin Study Group.
    Clin Ther; 2004 Sep 01; 26(9):1388-99. PubMed ID: 15531001
    [Abstract] [Full Text] [Related]

  • 19. Comparison of statins in hypertriglyceridemia.
    Stein EA, Lane M, Laskarzewski P.
    Am J Cardiol; 1998 Feb 26; 81(4A):66B-69B. PubMed ID: 9526817
    [Abstract] [Full Text] [Related]

  • 20. Is atorvastatin superior to other statins? Analysis of the clinical trials with atorvastatin having cardiovascular endpoints.
    Doggrell SA.
    Rev Recent Clin Trials; 2006 May 26; 1(2):143-53. PubMed ID: 18473965
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 59.